David E. Lanar

Phase I/IIa Safety, Immunogenicity, and Efficacy Trial of NYVAC‐Pf7, a Pox‐Vectored, Multiantigen, Multistage Vaccine Candidate for<i>Plasmodium falciparum</i>Malaria

Christian F. Ockenhouse, P. Sun, David E. Lanar et al. · The Journal of Infectious Diseases · 1998 · 224 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

João C. Aguiar, Richard C. Hedstrom, William O. Rogers et al. · Vaccine · 2001 · 100 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS,S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys

Sathit Pichyangkul, Pongsri Tongtawe, Utaiwan Kum-Arb et al. · Vaccine · 2009 · 38 citations

Veterinary Medicine, Immunology, Infectious Diseases +16

Induction of murine cytotoxic T lymphocytes against <i>Plasmodium falciparum</i> sporozoite surface protein 2

Benjamin Wizel, William O. Rogers, Richard A. Houghten et al. · European Journal of Immunology · 1994 · 19 citations

Veterinary Medicine, Immunology, Infectious Diseases +17